Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on LDK378. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for Ceritinib intermediate reduces cost and improves scalability. Reliable supplier for high-purity pharmaceutical intermediates.
Patent CN104447515A reveals a novel Ceritinib intermediate route avoiding expensive Platinum Dioxide. Discover cost reduction and high-purity supply chain solutions.